WST241220P440000
- 87.50
- 0.000.00%
West Pharmaceutical Services Newsroom
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
S&P 500, Dow Hit Records Right After Open | Live Stock
West Pharmaceutical Services Stock Outlook: Is Wall Street Bullish or Bearish?
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Market Falls on Retail Results, Bitcoin Swells, All Eyes on Nvidia | Live Stock
OLYBET Se Asocia Con WST
Jefferies Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Maintains Target Price $393
Jefferies Sticks to Their Buy Rating for West Pharmaceutical Services (WST)
Bitcoin Climbs to Fresh High, Market Shifts into Climb | Wall Street Today
Tuesday Market Falls, SMCI Flies, Big Box Retail Reports Mixed | Live Stock
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
Monday Market Slow but Steady, Trump Buying Crypto Firm | Wall Street Today
Monday Opens to S&P 500 Climb, Dow Slides as Eyes Look Toward Nvidia | Live Stock
Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'
West Pharmaceutical Services (NYSE:WST) Expands AI Solutions to Address Profit Challenges and Competition